股票 › UTHR
联合治疗公司 UTHR
$562.02 −$3.70 (-0.65%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $562.02 0.00%
开盘$561.95
昨收$565.72
当日区间$559.41 – $569.45
成交量468.6K
市值$23.94B
市盈率（TTM）21.2
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$783.30M-1.9% YoY
营业利润$330.80M-14.3% YoY
净利润$333.00M+7.6% YoY
摊薄每股收益$7.27+13.4% YoY
自由现金流$205.60M+58.8% YoY
经营现金流$313.60M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率86.1%
营业利润率44.5%
净利率41.6%
净资产收益率19.3%
资产收益率17.3%
投入资本回报率17.5%
流动比率5.73
负债/资产比率11.4%
现金及投资$2.66B
净现金（净负债）$2.66B
自由现金流/营收34.5%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $783.30M | $781.50M | $3.18B | $790.20M | $799.50M |
| 营业总收入 | $783.30M | $781.50M | $3.18B | $790.20M | $799.50M |
| 营业成本 | $99.50M | $133.40M | $384.40M | $103.40M | $100.90M |
| 毛利润 | $683.80M | $648.10M | $2.80B | $686.80M | $698.60M |
| 营业费用 | $353.00M | $322.30M | $1.28B | $329.30M | $309.30M |
| 销售及管理费用 | $206.70M | $184.10M | $731.10M | $189.80M | $181.80M |
| -销售及营销费用 | $37.30M | $28.70M | $118.60M | $32.70M | $28.30M |
| -管理费用 | $169.40M | $155.40M | $612.50M | $157.10M | $153.50M |
| 研发费用 | $146.30M | $138.20M | $550.00M | $139.50M | $127.50M |
| 营业利润 | $330.80M | $325.80M | $1.52B | $357.50M | $389.30M |
| 非经营性利息净收入（支出） | $28.60M | $38.80M | $172.50M | $40.10M | $43.40M |
| 非经营性利息收入 | $31.50M | $41.80M | $192.00M | $43.20M | $46.40M |
| 非经营性利息支出 | $2.90M | $3.00M | $19.50M | $3.10M | $3.00M |
| 其他收入（支出） | $13.30M | -$46.30M | $24.20M | $46.40M | $5.30M |
| 特殊收益（费用） | $0.00 | – | -$24.70M | -$800,000.00 | -$800,000.00 |
| -减：资本性资产减值 | $0.00 | – | $21.70M | $0.00 | $0.00 |
| 其他非经营性收入（支出） | $13.30M | -$46.30M | $48.90M | $47.20M | $6.10M |
| 税前利润 | $372.70M | $318.30M | $1.71B | $444.00M | $438.00M |
| 税费 | $39.70M | $43.40M | $379.20M | $79.70M | $99.30M |
| 净利润 | $333.00M | $274.90M | $1.33B | $364.30M | $338.70M |
| 持续经营利润 | $333.00M | $274.90M | $1.33B | $364.30M | $338.70M |
| 归属母公司净利润 | $333.00M | $274.90M | $1.33B | $364.30M | $338.70M |
| 归属普通股股东净利润 | $333.00M | $274.90M | $1.33B | $364.30M | $338.70M |
| 基本每股收益 | $7.82 | $6.32 | $30.13 | $8.41 | $7.73 |
| 摊薄每股收益 | $7.27 | $5.82 | $27.86 | $7.70 | $7.16 |
| -减：其他特殊支出 | – | – | $3.00M | $800,000.00 | $800,000.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $7.22B | $6.71B | $7.88B | $7.88B | $7.35B |
| 流动资产合计 | $3.48B | $2.87B | $3.70B | $3.70B | $3.49B |
| 现金及现金等价物与短期投资 | $2.66B | $2.15B | $2.92B | $2.92B | $2.77B |
| -现金及现金等价物 | $1.80B | $1.28B | $1.56B | $1.56B | $1.34B |
| -短期投资 | $859.10M | $874.00M | $1.36B | $1.36B | $1.43B |
| 应收款 | $310.30M | $312.00M | $350.20M | $350.20M | $297.70M |
| -应收账款 | $310.30M | $312.00M | $350.20M | $350.20M | $297.70M |
| 存货 | $193.80M | $178.30M | $183.10M | $183.10M | $176.50M |
| 其他流动资产 | $317.30M | $228.00M | $248.90M | $248.90M | $252.20M |
| 非流动资产合计 | $3.74B | $3.84B | $4.18B | $4.18B | $3.86B |
| 固定资产净值 | $1.93B | $1.84B | $1.73B | $1.73B | $1.56B |
| -固定资产原值 | $2.54B | $2.43B | $2.30B | $2.30B | $2.10B |
| -累计折旧 | -$612.10M | -$589.30M | -$567.80M | -$567.80M | -$548.60M |
| 投资及预付款 | $1.14B | $1.32B | $1.78B | $1.78B | $1.57B |
| -可供出售证券 | $1.14B | $1.32B | $1.78B | $1.78B | $1.57B |
| 商誉及其他无形资产 | $114.10M | $115.50M | $116.50M | $116.50M | $116.70M |
| 一年以上递延资产 | $311.60M | $335.40M | $357.70M | $357.70M | $354.90M |
| 其他非流动资产 | $239.50M | $233.20M | $196.90M | $196.90M | $262.60M |
| 负债合计 | $819.80M | $813.10M | $783.80M | $783.80M | $760.90M |
| 流动负债合计 | $607.80M | $599.10M | $560.60M | $560.60M | $546.30M |
| 其他流动负债 | $110.00M | $100.80M | $72.60M | $72.60M | $78.30M |
| 非流动负债合计 | $212.00M | $214.00M | $223.20M | $223.20M | $214.60M |
| 其他非流动负债 | $212.00M | $214.00M | $223.20M | $223.20M | $214.60M |
| 股东权益合计 | $6.40B | $5.90B | $7.10B | $7.10B | $6.59B |
| 股东权益 | $6.40B | $5.90B | $7.10B | $7.10B | $6.59B |
| 股本 | $800,000.00 | $800,000.00 | $800,000.00 | $800,000.00 | $800,000.00 |
| -普通股 | $800,000.00 | $800,000.00 | $800,000.00 | $800,000.00 | $800,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.90B | $2.52B | $2.80B | $2.80B | $2.66B |
| 留存收益 | $9.16B | $8.83B | $8.56B | $8.56B | $8.19B |
| 减：库存股 | $5.64B | $5.44B | $4.26B | $4.26B | $4.26B |
| 不影响留存收益的损益 | -$16.20M | -$10.20M | $900,000.00 | $900,000.00 | $100,000.00 |
| -商誉 | – | – | $32.30M | $32.30M | – |
| -其他无形资产 | – | – | $84.20M | $84.20M | – |
| 应付款 | – | – | $7.10M | $7.10M | – |
| -应付账款 | – | – | $7.10M | $7.10M | – |
| 一年内应计费用 | – | – | $480.90M | $480.90M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $313.60M | $463.30M | $1.56B | $346.20M | $562.10M |
| 持续经营经营活动现金流净额 | $313.60M | $463.30M | $1.56B | $346.20M | $562.10M |
| 持续经营净利润 | $333.00M | $274.90M | $1.33B | $364.30M | $338.70M |
| 持续经营损益 | -$13.40M | $61.60M | – | – | – |
| 折旧、折耗与摊销 | $24.20M | $22.60M | $85.60M | $22.80M | $21.90M |
| 递延税款 | $25.70M | $25.90M | $97.70M | – | – |
| 其他非现金项目 | $24.80M | $32.00M | -$19.70M | -$33.60M | $9.20M |
| 营运资金变动 | -$124.10M | $12.40M | -$106.50M | -$144.00M | $162.50M |
| -应收款变动 | $1.70M | $38.20M | -$70.90M | -$52.50M | $81.60M |
| -存货变动 | -$17.70M | -$40.10M | -$52.60M | -$16.50M | -$17.50M |
| -应付账款及应计费用变动 | -$4.00M | -$12.70M | $97.90M | $23.20M | $31.20M |
| -其他营运资金变动 | -$104.10M | $27.00M | -$80.90M | -$98.20M | $67.20M |
| 投资活动现金流净额 | $87.50M | $743.70M | -$551.30M | -$227.60M | $140.90M |
| 持续经营投资活动现金流净额 | $87.50M | $743.70M | -$551.30M | -$227.60M | $140.90M |
| 固定资产购置及出售净额 | -$108.00M | -$100.80M | -$520.50M | -$172.90M | -$210.50M |
| 业务购买及出售净额 | $0.00 | -$25.00M | -$55.00M | -$25.00M | -$30.00M |
| 投资购置及出售净额 | $196.20M | $875.20M | $40.10M | -$34.80M | $392.60M |
| 其他投资变动净额 | -$700,000.00 | -$5.70M | -$10.40M | $5.10M | -$5.70M |
| 筹资活动现金流 | $122.40M | -$1.48B | -$1.15B | $98.40M | -$956.00M |
| 持续经营筹资活动现金流净额 | $122.40M | -$1.48B | -$1.15B | $98.40M | -$956.00M |
| 债务发行及偿还净额 | $0.00 | $0.00 | -$300.00M | $0.00 | $0.00 |
| 普通股发行净额 | -$58.80M | -$1.50B | -$1.02B | $4.40M | -$1.00B |
| 股票期权行使所得 | $126.30M | $73.90M | $183.10M | $99.00M | $44.50M |
| 其他筹资费用净额 | $54.90M | -$58.30M | -$16.50M | -$5.00M | $0.00 |
| 期末现金余额 | $1.80B | $1.28B | $1.56B | $1.56B | $1.34B |
| 现金净变动 | $523.50M | -$277.40M | -$140.10M | $217.00M | -$253.00M |
| 期初现金余额 | $1.28B | $1.56B | $1.70B | $1.34B | $1.59B |
| 自由现金流 | $205.60M | $362.50M | $1.04B | $173.30M | $346.10M |
| 无形资产购置及出售净额 | – | – | -$5.50M | $0.00 | – |
暂无评论——快来第一个聊聊 UTHR。
登录后参与讨论。